Challenges to testing COVID-19 in conflict zones: Yemen as an example

doi:10.7189/jogh.10.010375

Review

. 2020 Jun;10(1):010375.

doi: 10.7189/jogh.10.010375.

Challenges to testing COVID-19 in conflict zones: Yemen as an example

Ghulam N Dhabaan¹, Walid A Al-Soneidar², Nezar N Al-Hebshi³

Affiliations

¹ Department of Microbiology, Mount Sinai Hospital & University Health Network - University of Toronto, Toronto, Canada.
² Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
³ Oral Microbiome Research Laboratory, Department of Oral Health Sciences, Kornberg School of Dentistry, Temple University, Philadelphia, Pennsylvania, USA.

PMID: 32582438
PMCID: PMC7307803
DOI: 10.7189/jogh.10.010375

Review

Challenges to testing COVID-19 in conflict zones: Yemen as an example

Ghulam N Dhabaan et al. J Glob Health. 2020 Jun.

. 2020 Jun;10(1):010375.

doi: 10.7189/jogh.10.010375.

Authors

Ghulam N Dhabaan¹, Walid A Al-Soneidar², Nezar N Al-Hebshi³

Affiliations

¹ Department of Microbiology, Mount Sinai Hospital & University Health Network - University of Toronto, Toronto, Canada.
² Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
³ Oral Microbiome Research Laboratory, Department of Oral Health Sciences, Kornberg School of Dentistry, Temple University, Philadelphia, Pennsylvania, USA.

PMID: 32582438
PMCID: PMC7307803
DOI: 10.7189/jogh.10.010375

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.

Figures

None — Photo: A PCR facility at the Central Public Health Laboratory in Taiz, Yemen, operating under limited resources and scarcity of tests. Photo taken by Taha Saleh (used with permission).

See this image and copyright information in PMC

Cited by

Multi-sectoral collaborations in selected countries of the Eastern Mediterranean region: assessment, enablers and missed opportunities from the COVID-19 pandemic response.
El-Jardali F, Fadlallah R, Daher N. El-Jardali F, et al. Health Res Policy Syst. 2024 Jan 24;22(1):14. doi: 10.1186/s12961-023-01098-z. Health Res Policy Syst. 2024. PMID: 38267995 Free PMC article.
Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, Yemen.
Koum Besson ES, Norris A, Bin Ghouth AS, Freemantle T, Alhaffar M, Vazquez Y, Reeve C, Curran PJ, Checchi F. Koum Besson ES, et al. BMJ Glob Health. 2021 Mar;6(3):e004564. doi: 10.1136/bmjgh-2020-004564. BMJ Glob Health. 2021. PMID: 33758012 Free PMC article.
High seroprevalence of antibodies against SARS-CoV-2 among healthcare workers 8 months after the first wave in Aden, Yemen.
Malaeb R, Yousef N, Al-Nagdah O, Ali QH, Saeed MAS, Haider A, Zelikova E, Malou N, Guiramand S, Mills C, Luquero F, Porten K. Malaeb R, et al. PLOS Glob Public Health. 2022 Nov 9;2(11):e0000767. doi: 10.1371/journal.pgph.0000767. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962647 Free PMC article.
Variant analysis of SARS-CoV-2 genomes in the Middle East.
Bindayna KM, Crinion S. Bindayna KM, et al. Microb Pathog. 2021 Apr;153:104741. doi: 10.1016/j.micpath.2021.104741. Epub 2021 Feb 13. Microb Pathog. 2021. PMID: 33588026 Free PMC article.
Comparison of machine learning techniques to handle imbalanced COVID-19 CBC datasets.
Dorn M, Grisci BI, Narloch PH, Feltes BC, Avila E, Kahmann A, Alho CS. Dorn M, et al. PeerJ Comput Sci. 2021 Aug 12;7:e670. doi: 10.7717/peerj-cs.670. eCollection 2021. PeerJ Comput Sci. 2021. PMID: 34458574 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization. PCR protocols for SARS-CoV2. Available: https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf. Accessed: 10 May 2020.
1. Foundation for Innovative New Diagnostics. SARS-CoV-2 Diagnostic Pipeline. Available: https://www.finddx.org/covid-19/pipeline/. Accessed: 10 May 2020.
1. U.S. Food and Drug Administration. Emergency Use Authorization: Emergency Use Authorization (EUA) information, and list of all current EUAs. Available: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regula.... Accessed: 10 May 2020.
1. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A narrative review. Ann Intern Med. 2020;172:726-34. 10.7326/M20-1301 - DOI - PMC - PubMed
1. Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. Test performance evaluation of SARS-CoV-2 serological assays. medRxiv. 2020:2020.04.25.20074856.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] World Health Organization. PCR protocols for SARS-CoV2. Available: https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf. Accessed: 10 May 2020.

[2] World Health Organization. PCR protocols for SARS-CoV2. Available: https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf. Accessed: 10 May 2020.

[3] Foundation for Innovative New Diagnostics. SARS-CoV-2 Diagnostic Pipeline. Available: https://www.finddx.org/covid-19/pipeline/. Accessed: 10 May 2020.

[4] Foundation for Innovative New Diagnostics. SARS-CoV-2 Diagnostic Pipeline. Available: https://www.finddx.org/covid-19/pipeline/. Accessed: 10 May 2020.

[5] U.S. Food and Drug Administration. Emergency Use Authorization: Emergency Use Authorization (EUA) information, and list of all current EUAs. Available: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regula.... Accessed: 10 May 2020.

[6] U.S. Food and Drug Administration. Emergency Use Authorization: Emergency Use Authorization (EUA) information, and list of all current EUAs. Available: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regula.... Accessed: 10 May 2020.

[7] Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A narrative review. Ann Intern Med. 2020;172:726-34. 10.7326/M20-1301 - DOI - PMC - PubMed

[8] Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A narrative review. Ann Intern Med. 2020;172:726-34. 10.7326/M20-1301 - DOI - PMC - PubMed

[9] Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. Test performance evaluation of SARS-CoV-2 serological assays. medRxiv. 2020:2020.04.25.20074856.

[10] Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. Test performance evaluation of SARS-CoV-2 serological assays. medRxiv. 2020:2020.04.25.20074856.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Challenges to testing COVID-19 in conflict zones: Yemen as an example

Affiliations

Challenges to testing COVID-19 in conflict zones: Yemen as an example

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical